US 10221226
LEDGF peptides and formulations thereof for treatment of degenerative disorders
granted A61KA61K38/00A61K38/18
Quick answer
US patent 10221226 (LEDGF peptides and formulations thereof for treatment of degenerative disorders) held by The Regents of the University of Colorado, a Body Corporate expires Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue Mar 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K38/00, A61K38/18, A61K47/52, A61K47/6929